Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis

Souza, Luciana Ângelo; Bastos, Matheus Silva e; Agripino, Joice de Melo; Onofre, Thiago Souza; Cala, Lourdes Fanny Apala; Heimburg, Tino; Ghazy, Ehab; Bayer, Theresa; Silva, Victor Hugo Ferraz da; Ribeiro, Paula Dutra; Oliveira, Leandro Licursi de; Bressan, Gustavo Costa; Lamêgo, Márcia Rogéria de Almeida; Silva Junior, Abelardo; Vasconcellos, Raphael de Souza; Suarez-Fontes, Ana Márcia; Silva, Juliana Almeida; Santos, Marcos André Vannier; Fietto, Juliana Lopes Rangel.
Artigo em Inglês | Arca: Repositório institucional da Fiocruz | ID: arc-45492

Documentos relacionados

  1. Curriculum vitae of CUG binding protein 1 (CELF1) in homeostasis and diseases: a systematic review.
  2. Epigenetic polypharmacology: A new frontier for epi-drug discovery.
  3. Targeting epigenetic modulators using PROTAC degraders: Current status and future perspective.
  4. Transitions in development - an interview with Antonio Scialdone.
  5. Construction of Multiple DNAzymes Driven by Single Base Elongation and Ligation for Single-Molecule Monitoring of FTO in Cancer Tissues.
  6. Epigenetic mechanisms and drug discovery in rheumatology.
  7. Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation.
  8. Recent progress on cheminformatics approaches to epigenetic drug discovery.
  9. [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Statistical genetics and rheumatoid arthritis.]
  10. DEEP-EP: Identification of epigenetic protein by ensemble residual convolutional neural network for drug discovery.